ClinConnect ClinConnect Logo
Search / Trial NCT03668821

Frailty in Vascular Patients Undergoing Surgery

Launched by IMPERIAL COLLEGE LONDON · Sep 10, 2018

Trial Information

Current as of November 08, 2025

Recruiting

Keywords

Vascular Diseases Peripheral Artery Disease

ClinConnect Summary

This clinical trial is studying how frailty affects patients who are having vascular surgery. Frailty refers to a state of increased vulnerability, which can make recovery from surgery more difficult. The researchers want to understand how frail patients do after surgeries such as aortic aneurysm repair, carotid artery surgery, and lower limb revascularization. This information will help improve care for future patients undergoing similar procedures.

The study is open to patients aged 65 to 74 who are scheduled for the surgeries mentioned above and are willing to provide consent to participate. If you join the study, you will be monitored during and after your surgery to track how well you recover. It's important to note that patients under 18, those who can't provide consent, or anyone deemed unable to follow the study requirements will not be eligible. This research aims to provide valuable insights into how different levels of frailty can influence surgical outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. All patients attending for aortic aneurysm repair, carotid artery surgery and lower limb revascularisation under the care of the Vascular Surgery team
  • 2. Willing and able to give informed written consent
  • Exclusion Criteria:
  • 1. Those unable to give informed written consent
  • 2. Those \<18 years of age
  • 3. In the opinion of the investigator unable or unwilling to comply with the requirements of the study

About Imperial College London

Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.

Locations

London, United Kingdom

London, United Kingdom

Patients applied

0 patients applied

Trial Officials

Alun H Davies, DM FRCS

Study Chair

Imperial College London

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials